Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 503
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00267696 | Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer | ||
| NCT03654638 | Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer | ||
| NCT01692340 | Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans | ||
| NCT07356245 | Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma | ||
| NCT05349227 | Comprehensive Outcomes for After Cancer Health | ||
| NCT04340531 | Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities | ||
| NCT06209619 | CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma | ||
| NCT02944565 | Daratumumab in Treating Patients With Multiple Myeloma | ||
| NCT01764789 | Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | ||
| NCT06424522 | A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients | ||
| NCT01460940 | A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma | ||
| NCT03749018 | Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma | ||
| NCT02950220 | Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | ||
| NCT02292524 | Prostate Biomarkers in Men Consuming Tomato Products | ||
| NCT00675259 | Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer | ||
| NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | ||
| NCT01501487 | MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I | ||
| NCT02439255 | Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers | ||
| NCT06630429 | A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors | ||
| NCT06026657 | Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer | ||
| NCT00837928 | Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | ||
| NCT06470971 | Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial | ||
| NCT04733495 | Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment | ||
| NCT02351505 | Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer | ||
| NCT02120222 | Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery | ||
| NCT03489213 | Nutrition and Exercise Trial: Improving Diet and Physical Activity Patterns in Overweight Cancer Survivors | ||
| NCT05418088 | Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies | ||
| NCT04906382 | Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer | ||
| NCT05864586 | Developing E-liquid Product Standards (Sweet Spot Study) | ||
| NCT00005035 | Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer | ||
| NCT05946668 | Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study | ||
| NCT00997243 | Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes | ||
| NCT05802797 | Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules | ||
| NCT05264532 | Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations | ||
| NCT00729118 | Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||
| NCT00362570 | Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma | ||
| NCT03199651 | Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer | ||
| NCT05821088 | Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma | ||
| NCT05984888 | Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer | ||
| NCT01696760 | Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology | ||
| NCT00201682 | Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | ||
| NCT03656835 | Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma | ||
| NCT00323323 | CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas | ||
| NCT02035527 | Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | ||
| NCT00024180 | FR901228 in Treating Patients With Hematologic Cancer | ||
| NCT01174888 | Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT00201773 | Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | ||
| NCT04938869 | Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer | ||
| NCT03039140 | Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors | ||
| NCT05869318 | Respiratory Effects of E-Cigarettes in Obese Youth |
